China Resources Fair Value
60
The fair market value of 600062.SS stock is 16.6 CNY. Relative to the market price of 24.2 CNY China Resources is overvalued by 31.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
China Resources Valuation
Current 600062.SS share ticker price is 24.2 CNY.
The fair value level of 16.6 CNY can be considered as an effective entry point for long-term investors to start investing in 600062.SS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 31% higher its fair value
Current price is 39% higher its minimum value
Current price is 15% higher its maximum value
Market price:
600062.SS stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
China Resources Double-Crane Pharmaceutical Co Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
16.97
2
Median P/E over 5 years
13.71
3
Minimum P/E over 5 years
12.12
4
Earning per share (last 12 months)
1.21 CNY
Maximum value
1
x
4
=
20.56 CNY
Fair value
2
x
4
=
16.6 CNY
Minimum value
3
x
4
=
14.68 CNY
China Resources Double-Crane Pharmaceutical Co Ltd price metrics
12.8
Annual return (geometric mean)
38.7
Risk (standard deviation) of returns
β
1.0
Beta (volatility compared to market)